XML 103 R83.htm IDEA: XBRL DOCUMENT v3.21.2
Equity-Accounted Investments And Other Long-Term Assets (Summary Of Movement In Equity-Accounted Investments) (Details) - USD ($)
 3 Months Ended 12 Months Ended
Apr. 01, 2020
Mar. 31, 2020
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Schedule of Equity Method Investments [Line Items]              
Balance       $ 290,213,000 $ 290,213,000 $ 317,342,000 $ 734,926,000
Net (loss) income         (38,057,000) (78,358,000) [1] (308,658,000) [1]
Balance         275,980,000 290,213,000 317,342,000
Balance at beginning of period       78,486,000 78,486,000    
Loans granted         1,238,000 1,230,000 0
Balance at end of period         67,371,000 78,486,000  
Equity-accounted Investees [Member]              
Schedule of Equity Method Investments [Line Items]              
Balance       65,216,000 65,216,000 148,279,000  
Acquisition of shares           2,774,000  
Stock-based compensation         (25,000) 71,000  
Comprehensive (loss) income         (26,845,000) (27,315,000)  
Other comprehensive income         (1,967,000) 2,227,000  
Net (loss) income         (24,878,000) (29,542,000)  
Share of net income (loss) (Note 1)         (3,734,000) 6,089,000  
Amortization - acquired intangible assets           (2,443,000)  
Deferred taxes - acquired intangible assets           660,000  
Dilution resulting from corporate transactions           (17,000)  
Impairment         (21,144,000) (33,831,000)  
Dividends received         (194,000) (3,823,000)  
Sale of DNI         (32,905,000) (36,508,000)  
Foreign currency adjustment         4,757,000 (18,262,000)  
Balance         10,004,000 65,216,000 148,279,000
Balance at beginning of period       620,000 620,000 148,000  
Loans repaid         (134,000)    
Loans granted         1,238,000 1,230,000  
Allowance for doubtful loans         (1,738,000) (730,000)  
Foreign currency adjustment         14,000 (28,000)  
Balance at end of period         0 620,000 148,000
Finbond [Member]              
Schedule of Equity Method Investments [Line Items]              
Impairment     $ (800,000) (16,800,000) (17,700,000)    
Finbond [Member] | Equity-accounted Investees [Member]              
Schedule of Equity Method Investments [Line Items]              
Balance       30,876,000 30,876,000 32,611,000  
Acquisition of shares           274,000  
Stock-based compensation         (25,000) 71,000  
Comprehensive (loss) income         (23,976,000) 4,067,000  
Other comprehensive income         (1,967,000) 2,227,000  
Net (loss) income         (22,009,000) 1,840,000  
Share of net income (loss) (Note 1)         (4,359,000) 1,857,000  
Amortization - acquired intangible assets           0  
Deferred taxes - acquired intangible assets           0  
Dilution resulting from corporate transactions           (17,000)  
Impairment         (17,650,000) 0  
Dividends received         0 (274,000)  
Sale of DNI         0 0  
Foreign currency adjustment         2,947,000 (5,873,000)  
Balance         9,822,000 30,876,000 32,611,000
Balance at beginning of period       0 0 0  
Loans repaid         0    
Loans granted         0 0  
Allowance for doubtful loans         0 0  
Foreign currency adjustment         0 0  
Balance at end of period         0 0 0
Bank Frick [Member] | Equity-accounted Investees [Member]              
Schedule of Equity Method Investments [Line Items]              
Balance       29,739,000 29,739,000 47,240,000  
Acquisition of shares           0  
Stock-based compensation         0 0  
Comprehensive (loss) income         1,156,000 (17,273,000)  
Other comprehensive income         0 0  
Net (loss) income         1,156,000 (17,273,000)  
Share of net income (loss) (Note 1)         1,156,000 1,421,000  
Amortization - acquired intangible assets           (569,000)  
Deferred taxes - acquired intangible assets           136,000  
Dilution resulting from corporate transactions           0  
Impairment         0 (18,261,000)  
Dividends received         0 (1,308,000)  
Sale of DNI         (32,892,000) 0  
Foreign currency adjustment         1,997,000 1,080,000  
Balance         0 29,739,000 47,240,000
Balance at beginning of period       0 0 0  
Loans repaid         0    
Loans granted         0 0  
Allowance for doubtful loans         0 0  
Foreign currency adjustment         0 0  
Balance at end of period         0 0 0
DNI [Member]              
Schedule of Equity Method Investments [Line Items]              
Impairment $ (11,500,000) $ (1,600,000)       (13,100,000)  
DNI [Member] | Equity-accounted Investees [Member]              
Schedule of Equity Method Investments [Line Items]              
Balance       0 0 61,030,000  
Acquisition of shares           0  
Stock-based compensation         0 0  
Comprehensive (loss) income         0 (9,744,000)  
Other comprehensive income         0 0  
Net (loss) income         0 (9,744,000)  
Share of net income (loss) (Note 1)         0 4,676,000  
Amortization - acquired intangible assets           (1,874,000)  
Deferred taxes - acquired intangible assets           524,000  
Dilution resulting from corporate transactions           0  
Impairment         0 (13,070,000)  
Dividends received         0 (1,787,000)  
Sale of DNI         0 (36,508,000)  
Foreign currency adjustment         0 (12,991,000)  
Balance         0 0 61,030,000
Balance at beginning of period       0 0 0  
Loans repaid         0    
Loans granted         0 0  
Allowance for doubtful loans         0 0  
Foreign currency adjustment         0 0  
Balance at end of period         0 0 0
Other [Member] | Equity-accounted Investees [Member]              
Schedule of Equity Method Investments [Line Items]              
Balance       4,601,000 4,601,000 7,398,000  
Acquisition of shares           2,500,000  
Stock-based compensation         0 0  
Comprehensive (loss) income         (4,025,000) (4,365,000)  
Other comprehensive income         0 0  
Net (loss) income         (4,025,000) (4,365,000)  
Share of net income (loss) (Note 1)         (531,000) (1,865,000)  
Amortization - acquired intangible assets           0  
Deferred taxes - acquired intangible assets           0  
Dilution resulting from corporate transactions           0  
Impairment         (3,494,000) (2,500,000)  
Dividends received         (194,000) (454,000)  
Sale of DNI         (13,000) 0  
Foreign currency adjustment         (187,000) (478,000)  
Balance         182,000 4,601,000 7,398,000
Balance at beginning of period       $ 620,000 620,000 148,000  
Loans repaid         (134,000)    
Loans granted         1,238,000 1,230,000  
Allowance for doubtful loans         (1,738,000) (730,000)  
Foreign currency adjustment         14,000 (28,000)  
Balance at end of period         $ 0 $ 620,000 $ 148,000
[1] <div>Certain amounts have been restated to correct the misstatement discussed in Note 1.</div>